A Randomized, Double-blind, Double-dummy, Three Period Incomplete Cross-over Study to Evaluate the Safety and Efficacy of Multiple Daily Doses of QAX028 as Compared to Tiotropium Bromide (Positive Control) and Placebo in COPD Patients.
Phase of Trial: Phase II
Latest Information Update: 03 May 2012
At a glance
- Drugs QAX 028; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 25 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 25 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2010 New trial record